SlideShare a Scribd company logo
1 of 6
The IROATM
methodology was developed to
automate and simplify metabolomics so that
investigators can achieve clear and reliable results
easily. It only requires suitable isotopically-paired
media and software to extract and process the
mass spectrometer raw data files. The following
slides describe an IROA experiment in its simplest
form. This basic methodology may be just as
easily applied to simple experimental systems or
much more complex experimental systems, only a
change in cell medium is required.
IROA™: Isotopic Ratio Outlier Analysis
media-free
cells
Wash
Culture
Biological
A. The use of a pooled biological population at the outset of the experiment
will reduce biological variance. The pooled biological population is divided
into two and each of these is placed in separate isotopically defined media.
B. The control and experimental cells are each allowed to grow through
enough divisions to dilute out the natural abundance carbon and replace it
with the characteristic isotopic distributions of their particular media. This
gives each and every molecule a unique “label”, definitive to source. The
experimental conditions are applied to the experimental population, and
vehicle to the control population.
The IROA™ Analysis
95% 12
C
and 5% 13
C
media
control
Experimental
TreatIncubate
Experimental
95% 13
C
and 5% 12
C
media
drug etc.
Add toxin,
Composite
media-free
12
cells
+
media-free
13
cells
Total Ion
Data
Analytical
The IROA™ Analysis
C. After the experimentally defined period the
experimental and control cells are mixed.
D. The mixed sample, containing both control and
experimental populations in one sample, is
prepared and analyzed by mass spectrometry as a
single sample. The number of samples to be
analyzed is reduced by half.
As all of the molecules from each population are
distinguishable from one another AND from artifactual
molecules, it is possible to look at any peak and
understand its origin. In addition, since the control and
experimental populations share the same handling-
induced variances compound–by-compound (i.e. error or
losses), there is no variance between or within them. This
“noise-free” environment is a unique feature of IROA
TM
, and
is the most significant reason for its success.
E. Artifacts are discarded; the respective areas for control-derived
and experimentally-derived compounds are identified (by isotopic
signature) and compared (by ratio).
F. The distribution of ratios is analyzed for outliers. Compounds with
abnormal ratios are molecules affected by the experimental stressor,
(toxin, drug etc.) allowing for clear interpretation.
Normalized
Ratio
0
-5.0
5.0
The IROA™ Analysis
IROA Software data flow
Normalized
Ratio
0
-5.0
5.0
108
datapoints (mostly noise)
B.
C.
A.
5X102
datapoints (pure data)
Variance control,
Data reduction,
Noise removal,
Data definition
Fully automated data reduction of complex raw data to concise, high value information.
The IROATM
software is capable of interpreting these datasets, and
will allow for a very dramatic reduction in data size as it easily
sorts through the dataset removing irrelevant data. No other
system can do this as efficiently or consistently.
IROA Software data flow
Normalized
Ratio
0
-5.0
5.0
108
datapoints (mostly noise)
B.
C.
A.
5X102
datapoints (pure data)
Variance control,
Data reduction,
Noise removal,
Data definition
Fully automated data reduction of complex raw data to concise, high value information.
The IROATM
software is capable of interpreting these datasets, and
will allow for a very dramatic reduction in data size as it easily
sorts through the dataset removing irrelevant data. No other
system can do this as efficiently or consistently.

More Related Content

What's hot

Standard practice for characterization of particles astm
Standard practice for characterization of particles astmStandard practice for characterization of particles astm
Standard practice for characterization of particles astmInkalloys Perú
 
Qsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar aloneQsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar alonesagar alone
 
Data analysis and Visualisation Techniques for Compound Combination Modelling
Data analysis and Visualisation Techniques for Compound Combination ModellingData analysis and Visualisation Techniques for Compound Combination Modelling
Data analysis and Visualisation Techniques for Compound Combination ModellingRichard Lewis
 
QSAR Studies of the Inhibitory Activity of a Series of Substituted Indole and...
QSAR Studies of the Inhibitory Activity of a Series of Substituted Indole and...QSAR Studies of the Inhibitory Activity of a Series of Substituted Indole and...
QSAR Studies of the Inhibitory Activity of a Series of Substituted Indole and...inventionjournals
 
An Introduction to:In Vitro-In VivoExtrapolation (IVIVE)
An Introduction to:In Vitro-In VivoExtrapolation (IVIVE)An Introduction to:In Vitro-In VivoExtrapolation (IVIVE)
An Introduction to:In Vitro-In VivoExtrapolation (IVIVE)mjamei
 
Advanced Systems Biology Methods in Drug Discovery
Advanced Systems Biology Methods in Drug DiscoveryAdvanced Systems Biology Methods in Drug Discovery
Advanced Systems Biology Methods in Drug DiscoveryMikel Txopitea Elorriaga
 

What's hot (10)

Standard practice for characterization of particles astm
Standard practice for characterization of particles astmStandard practice for characterization of particles astm
Standard practice for characterization of particles astm
 
Qsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar aloneQsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar alone
 
iTRAQ Technique
iTRAQ TechniqueiTRAQ Technique
iTRAQ Technique
 
Data analysis and Visualisation Techniques for Compound Combination Modelling
Data analysis and Visualisation Techniques for Compound Combination ModellingData analysis and Visualisation Techniques for Compound Combination Modelling
Data analysis and Visualisation Techniques for Compound Combination Modelling
 
QSAR Studies of the Inhibitory Activity of a Series of Substituted Indole and...
QSAR Studies of the Inhibitory Activity of a Series of Substituted Indole and...QSAR Studies of the Inhibitory Activity of a Series of Substituted Indole and...
QSAR Studies of the Inhibitory Activity of a Series of Substituted Indole and...
 
2 d gel analysis
2 d gel analysis2 d gel analysis
2 d gel analysis
 
Metabolomics
MetabolomicsMetabolomics
Metabolomics
 
Microarray
MicroarrayMicroarray
Microarray
 
An Introduction to:In Vitro-In VivoExtrapolation (IVIVE)
An Introduction to:In Vitro-In VivoExtrapolation (IVIVE)An Introduction to:In Vitro-In VivoExtrapolation (IVIVE)
An Introduction to:In Vitro-In VivoExtrapolation (IVIVE)
 
Advanced Systems Biology Methods in Drug Discovery
Advanced Systems Biology Methods in Drug DiscoveryAdvanced Systems Biology Methods in Drug Discovery
Advanced Systems Biology Methods in Drug Discovery
 

Similar to How the IROA Technology Works

Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014LushPrize
 
2 partners ed_kickoff_dtai
2 partners ed_kickoff_dtai2 partners ed_kickoff_dtai
2 partners ed_kickoff_dtaiSirris
 
1501 Refocus metabolomics
1501 Refocus metabolomics1501 Refocus metabolomics
1501 Refocus metabolomicsIS-X
 
Mass Spectrometry Applications and spectral interpretation: Basics
Mass Spectrometry Applications and spectral interpretation: BasicsMass Spectrometry Applications and spectral interpretation: Basics
Mass Spectrometry Applications and spectral interpretation: BasicsShreekant Deshpande
 
An Empirical Analysis of Ensemble Systems in Cancellable Behavioural Biometri...
An Empirical Analysis of Ensemble Systems in Cancellable Behavioural Biometri...An Empirical Analysis of Ensemble Systems in Cancellable Behavioural Biometri...
An Empirical Analysis of Ensemble Systems in Cancellable Behavioural Biometri...Marcelo Damasceno de Melo
 
Discrimination of symbiotic/parasitic bacterial type III secretion system eff...
Discrimination of symbiotic/parasitic bacterial type III secretion system eff...Discrimination of symbiotic/parasitic bacterial type III secretion system eff...
Discrimination of symbiotic/parasitic bacterial type III secretion system eff...Y-h Taguchi
 
AsedaSciences SLAS2017 poster presentation
AsedaSciences SLAS2017 poster presentationAsedaSciences SLAS2017 poster presentation
AsedaSciences SLAS2017 poster presentationAndrew Bieberich
 
LAOS in cosmetics_Ozkan etal
LAOS in cosmetics_Ozkan etalLAOS in cosmetics_Ozkan etal
LAOS in cosmetics_Ozkan etalSEHER OZKAN
 
IRJET- Disease Identification using Proteins Values and Regulatory Modules
IRJET-  	  Disease Identification using Proteins Values and Regulatory  ModulesIRJET-  	  Disease Identification using Proteins Values and Regulatory  Modules
IRJET- Disease Identification using Proteins Values and Regulatory ModulesIRJET Journal
 
Unc slides on computational toxicology
Unc slides on computational toxicologyUnc slides on computational toxicology
Unc slides on computational toxicologySean Ekins
 
MultiskanFC-antioxidant-power
MultiskanFC-antioxidant-powerMultiskanFC-antioxidant-power
MultiskanFC-antioxidant-powerArto Per
 
Biomaterials -Biocompatibility and characteristics
Biomaterials -Biocompatibility and characteristicsBiomaterials -Biocompatibility and characteristics
Biomaterials -Biocompatibility and characteristicstumainimatandala1
 
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...Sean Ekins
 
Back Rapid lead compounds discovery through high-throughput screening
 Back Rapid lead compounds discovery through high-throughput screening Back Rapid lead compounds discovery through high-throughput screening
Back Rapid lead compounds discovery through high-throughput screeningrita martin
 
Classification of Microarray Gene Expression Data by Gene Combinations using ...
Classification of Microarray Gene Expression Data by Gene Combinations using ...Classification of Microarray Gene Expression Data by Gene Combinations using ...
Classification of Microarray Gene Expression Data by Gene Combinations using ...IJCSEA Journal
 
2013 - Correlating exoenzyme activities, operacional parameters, cellular via...
2013 - Correlating exoenzyme activities, operacional parameters, cellular via...2013 - Correlating exoenzyme activities, operacional parameters, cellular via...
2013 - Correlating exoenzyme activities, operacional parameters, cellular via...WALEBUBLÉ
 

Similar to How the IROA Technology Works (20)

Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014Grafström - Lush Prize Conference 2014
Grafström - Lush Prize Conference 2014
 
2 partners ed_kickoff_dtai
2 partners ed_kickoff_dtai2 partners ed_kickoff_dtai
2 partners ed_kickoff_dtai
 
1501 Refocus metabolomics
1501 Refocus metabolomics1501 Refocus metabolomics
1501 Refocus metabolomics
 
Mass Spectrometry Applications and spectral interpretation: Basics
Mass Spectrometry Applications and spectral interpretation: BasicsMass Spectrometry Applications and spectral interpretation: Basics
Mass Spectrometry Applications and spectral interpretation: Basics
 
An Empirical Analysis of Ensemble Systems in Cancellable Behavioural Biometri...
An Empirical Analysis of Ensemble Systems in Cancellable Behavioural Biometri...An Empirical Analysis of Ensemble Systems in Cancellable Behavioural Biometri...
An Empirical Analysis of Ensemble Systems in Cancellable Behavioural Biometri...
 
Discrimination of symbiotic/parasitic bacterial type III secretion system eff...
Discrimination of symbiotic/parasitic bacterial type III secretion system eff...Discrimination of symbiotic/parasitic bacterial type III secretion system eff...
Discrimination of symbiotic/parasitic bacterial type III secretion system eff...
 
ERVA-NMR
ERVA-NMRERVA-NMR
ERVA-NMR
 
AsedaSciences SLAS2017 poster presentation
AsedaSciences SLAS2017 poster presentationAsedaSciences SLAS2017 poster presentation
AsedaSciences SLAS2017 poster presentation
 
LAOS in cosmetics_Ozkan etal
LAOS in cosmetics_Ozkan etalLAOS in cosmetics_Ozkan etal
LAOS in cosmetics_Ozkan etal
 
IRJET- Disease Identification using Proteins Values and Regulatory Modules
IRJET-  	  Disease Identification using Proteins Values and Regulatory  ModulesIRJET-  	  Disease Identification using Proteins Values and Regulatory  Modules
IRJET- Disease Identification using Proteins Values and Regulatory Modules
 
Techniques in proteomics
Techniques in proteomicsTechniques in proteomics
Techniques in proteomics
 
Introduction to Metagenomics Data Analysis - UEB-VHIR - 2013
Introduction to Metagenomics Data Analysis - UEB-VHIR - 2013Introduction to Metagenomics Data Analysis - UEB-VHIR - 2013
Introduction to Metagenomics Data Analysis - UEB-VHIR - 2013
 
Unc slides on computational toxicology
Unc slides on computational toxicologyUnc slides on computational toxicology
Unc slides on computational toxicology
 
MultiskanFC-antioxidant-power
MultiskanFC-antioxidant-powerMultiskanFC-antioxidant-power
MultiskanFC-antioxidant-power
 
Biomaterials -Biocompatibility and characteristics
Biomaterials -Biocompatibility and characteristicsBiomaterials -Biocompatibility and characteristics
Biomaterials -Biocompatibility and characteristics
 
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...
 
Back Rapid lead compounds discovery through high-throughput screening
 Back Rapid lead compounds discovery through high-throughput screening Back Rapid lead compounds discovery through high-throughput screening
Back Rapid lead compounds discovery through high-throughput screening
 
Classification of Microarray Gene Expression Data by Gene Combinations using ...
Classification of Microarray Gene Expression Data by Gene Combinations using ...Classification of Microarray Gene Expression Data by Gene Combinations using ...
Classification of Microarray Gene Expression Data by Gene Combinations using ...
 
2013 - Correlating exoenzyme activities, operacional parameters, cellular via...
2013 - Correlating exoenzyme activities, operacional parameters, cellular via...2013 - Correlating exoenzyme activities, operacional parameters, cellular via...
2013 - Correlating exoenzyme activities, operacional parameters, cellular via...
 
Matrix Effect
Matrix EffectMatrix Effect
Matrix Effect
 

How the IROA Technology Works

  • 1. The IROATM methodology was developed to automate and simplify metabolomics so that investigators can achieve clear and reliable results easily. It only requires suitable isotopically-paired media and software to extract and process the mass spectrometer raw data files. The following slides describe an IROA experiment in its simplest form. This basic methodology may be just as easily applied to simple experimental systems or much more complex experimental systems, only a change in cell medium is required. IROA™: Isotopic Ratio Outlier Analysis
  • 2. media-free cells Wash Culture Biological A. The use of a pooled biological population at the outset of the experiment will reduce biological variance. The pooled biological population is divided into two and each of these is placed in separate isotopically defined media. B. The control and experimental cells are each allowed to grow through enough divisions to dilute out the natural abundance carbon and replace it with the characteristic isotopic distributions of their particular media. This gives each and every molecule a unique “label”, definitive to source. The experimental conditions are applied to the experimental population, and vehicle to the control population. The IROA™ Analysis 95% 12 C and 5% 13 C media control Experimental TreatIncubate Experimental 95% 13 C and 5% 12 C media drug etc. Add toxin,
  • 3. Composite media-free 12 cells + media-free 13 cells Total Ion Data Analytical The IROA™ Analysis C. After the experimentally defined period the experimental and control cells are mixed. D. The mixed sample, containing both control and experimental populations in one sample, is prepared and analyzed by mass spectrometry as a single sample. The number of samples to be analyzed is reduced by half. As all of the molecules from each population are distinguishable from one another AND from artifactual molecules, it is possible to look at any peak and understand its origin. In addition, since the control and experimental populations share the same handling- induced variances compound–by-compound (i.e. error or losses), there is no variance between or within them. This “noise-free” environment is a unique feature of IROA TM , and is the most significant reason for its success.
  • 4. E. Artifacts are discarded; the respective areas for control-derived and experimentally-derived compounds are identified (by isotopic signature) and compared (by ratio). F. The distribution of ratios is analyzed for outliers. Compounds with abnormal ratios are molecules affected by the experimental stressor, (toxin, drug etc.) allowing for clear interpretation. Normalized Ratio 0 -5.0 5.0 The IROA™ Analysis
  • 5. IROA Software data flow Normalized Ratio 0 -5.0 5.0 108 datapoints (mostly noise) B. C. A. 5X102 datapoints (pure data) Variance control, Data reduction, Noise removal, Data definition Fully automated data reduction of complex raw data to concise, high value information. The IROATM software is capable of interpreting these datasets, and will allow for a very dramatic reduction in data size as it easily sorts through the dataset removing irrelevant data. No other system can do this as efficiently or consistently.
  • 6. IROA Software data flow Normalized Ratio 0 -5.0 5.0 108 datapoints (mostly noise) B. C. A. 5X102 datapoints (pure data) Variance control, Data reduction, Noise removal, Data definition Fully automated data reduction of complex raw data to concise, high value information. The IROATM software is capable of interpreting these datasets, and will allow for a very dramatic reduction in data size as it easily sorts through the dataset removing irrelevant data. No other system can do this as efficiently or consistently.